These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17990221)

  • 1. Extensively drug-resistant Mycobacterium tuberculosis: Charles Darwin would understand.
    Iseman MD
    Clin Infect Dis; 2007 Dec; 45(11):1415-6. PubMed ID: 17990221
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis. Few mutations divide some drug-resistant TB strains.
    Koenig R
    Science; 2007 Nov; 318(5852):901-2. PubMed ID: 17991835
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolution of the extensively drug-resistant F15/LAM4/KZN strain of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.
    Pillay M; Sturm AW
    Clin Infect Dis; 2007 Dec; 45(11):1409-14. PubMed ID: 17990220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trench warfare in a battle with TB.
    Marshall E
    Science; 2008 Jul; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract]   [Full Text] [Related]  

  • 5. Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results.
    Migliori GB; Lange C; Girardi E; Centis R; Besozzi G; Kliiman K; Ortmann J; Matteelli A; Spanevello A; Cirillo DM;
    Clin Infect Dis; 2008 Mar; 46(6):958-9. PubMed ID: 18288911
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug-resistant tuberculosis: reality and potential threat.
    Lalloo UG
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):255-8. PubMed ID: 20132610
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug-resistant tuberculosis. In South Africa, XDR TB and HIV prove a deadly combination.
    Koenig R
    Science; 2008 Feb; 319(5865):894-7. PubMed ID: 18276863
    [No Abstract]   [Full Text] [Related]  

  • 8. Extensively drug-resistant tuberculosis: current challenges and threats.
    Jain A; Mondal R
    FEMS Immunol Med Microbiol; 2008 Jul; 53(2):145-50. PubMed ID: 18479439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Totally drug-resistant tuberculosis in India.
    Udwadia ZF; Amale RA; Ajbani KK; Rodrigues C
    Clin Infect Dis; 2012 Feb; 54(4):579-81. PubMed ID: 22190562
    [No Abstract]   [Full Text] [Related]  

  • 10. Directly observed and standardized treatment in an era of extensively drug-resistant tuberculosis.
    Chang KC; Leung CC; Tam CM
    Clin Infect Dis; 2009 Jun; 48(11):1632-3; author reply 1633-4. PubMed ID: 19416026
    [No Abstract]   [Full Text] [Related]  

  • 11. Acquired rifamycin resistance: pharmacology and biology.
    Wallis RS; Weyer K; Fourie PB
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):223-30. PubMed ID: 18380604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ad fontes!
    Hoffner SE; Salfinger M
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):260. PubMed ID: 20132612
    [No Abstract]   [Full Text] [Related]  

  • 13. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insight into extremely drug-resistant tuberculosis: using atomic force microscopy.
    Velayati AA; Farnia P; Merza MA; Zhavnerko GK; Tabarsi P; Titov LP; Ghanavei J; Farnia P; Setare M; Poleschuyk NN; Owlia P; Sheikolslami M; Ranjbar R; Masjedi MR
    Eur Respir J; 2010 Dec; 36(6):1490-3. PubMed ID: 21119210
    [No Abstract]   [Full Text] [Related]  

  • 15. XDR Tuberculosis: a report from the New Delhi Tuberculosis Centre, India.
    Dhingra VK; Malik S; Hanif M; Arora VK
    J Coll Physicians Surg Pak; 2009 Feb; 19(2):133-5. PubMed ID: 19208323
    [No Abstract]   [Full Text] [Related]  

  • 16. Acquisition of bedaquiline resistance by extensively drug-resistant Mycobacterium tuberculosis strain of Central Asian Outbreak clade.
    Mokrousov I; Akhmedova G; Polev D; Molchanov V; Vyazovaya A
    Clin Microbiol Infect; 2019 Oct; 25(10):1295-1297. PubMed ID: 31229592
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the in vitro and intracellular efficacy of new monosubstituted sulfonylureas against extensively drug-resistant tuberculosis.
    Wang D; Pan L; Cao G; Lei H; Meng X; He J; Dong M; Li Z; Liu Z
    Int J Antimicrob Agents; 2012 Nov; 40(5):463-6. PubMed ID: 22867883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SILA 421, an inhibitor of efflux pumps of cancer cells, enhances the killing of intracellular extensively drug-resistant tuberculosis (XDR-TB).
    Martins M; Viveiros M; Ramos J; Couto I; Molnar J; Boeree M; Amaral L
    Int J Antimicrob Agents; 2009 May; 33(5):479-82. PubMed ID: 19155160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensively drug-resistant (XDR) tuberculosis: an old and new threat.
    Fattorini L; Migliori GB; Cassone A
    Ann Ist Super Sanita; 2007; 43(4):317-9. PubMed ID: 18209265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting human macrophages for enhanced killing of intracellular XDR-TB and MDR-TB.
    Martins M; Viveiros M; Couto I; Amaral L
    Int J Tuberc Lung Dis; 2009 May; 13(5):569-73. PubMed ID: 19383188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.